Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus

por van Vollenhoven, Ronald F, Kalunian, Kenneth C, Dörner, Thomas, Hahn, Bevra H, Tanaka, Yoshiya, Gordon, Robert M, Shu, Cathye, Fei, Kaiyin, Gao, Sheng, Seridi, Loqmane, Gallagher, Patrick, Lo, Kim Hung, Berry, Pamela, Zuraw, Qing C
Publicado 2022

Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillanc...

por Balanescu, Andra-Rodica, Citera, Gustavo, Pascual-Ramos, Virginia, Bhatt, Deepak L, Connell, Carol A, Gold, David, Chen, All-Shine, Sawyerr, Gosford, Shapiro, Andrea B, Pope, Janet E, Schulze-Koops, Hendrik
Publicado 2022

Distinct immune-effector and metabolic profile of CD8(+) T cells in patients with autoimmune polyarthritis induced by therapy with immune checkpoint inhibitors

por Benesova, Karolina, Kraus, Franziska Viktoria, Carvalho, Rui A, Lorenz, Holger, Hörth, Christian H, Günther, Janine, Klika, Karel D, Graf, Jürgen, Diekmann, Leonore, Schank, Timo, Christopoulos, Petros, Hassel, Jessica C, Lorenz, Hanns-Martin, Souto-Carneiro, Margarida
Publicado 2022

Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

por Brunner, Hermine I, Foeldvari, Ivan, Alexeeva, Ekaterina, Ayaz, Nuray Aktay, Calvo Penades, Inmaculada, Kasapcopur, Ozgur, Chasnyk, Vyacheslav G, Hufnagel, Markus, Żuber, Zbigniew, Schulert, Grant, Ozen, Seza, Rakhimyanova, Adelina, Ramanan, Athimalaipet, Scott, Christiaan, Sozeri, Betul, Zholobova, Elena, Martin, Ruvie, Zhu, Xuan, Whelan, Sarah, Pricop, Luminita, Martini, Alberto, Lovell, Daniel, Ruperto, Nicolino
Publicado 2023

American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision

por Studenic, Paul, Aletaha, Daniel, de Wit, Maarten, Stamm, Tanja A, Alasti, Farideh, Lacaille, Diane, Smolen, Josef S, Felson, David T
Publicado 2023

Predicting the risk of a clinical event using longitudinal data: the generalized landmark analysis

por Yao, Yi, Li, Liang, Astor, Brad, Yang, Wei, Greene, Tom
Publicado 2023

Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports

por Petri, Michelle, Landy, Helain, Clowse, Megan E B, Gemzoe, Kim, Khamashta, Munther, Kurtinecz, Milena, Levy, Roger A, Liu, Andrew, Marino, Rebecca, Meizlik, Paige, Pimenta, Jeanne M, Sumner, Kelsey, Tilson, Hugh, Connolly, Mary Beth, Wurst, Keele, Harris, Julia, Quasny, Holly, Juliao, Patricia, Roth, David A
Publicado 2023

Temporal trends and determinants of COVID-19 vaccine coverage and series initiation during pregnancy in Ontario, Canada, December 2020 to December 2021: A population-based retrospe...

por Fell, Deshayne B., Török, Eszter, Sprague, Ann E., Regan, Annette K., Dhinsa, Tavleen, Alton, Gillian D., Dimanlig-Cruz, Sheryll, MacDonald, Shannon E., Buchan, Sarah A., Kwong, Jeffrey C., Wilson, Sarah E., Håberg, Siri E., Gravel, Christopher A., Wilson, Kumanan, Dunn, Sandra I., Shah, Prakesh S., El-Chaâr, Darine, Barrett, Jon, Walker, Mark C., Okun, Nannette, Dougan, Shelley D.
Publicado 2023

Deciphering the role of cDC2s in Sjögren’s syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity

por Lopes, Ana P, Hillen, Maarten R, Hinrichs, Anneline C, Blokland, Sofie LM, Bekker, Cornelis PJ, Pandit, Aridaman, Kruize, Aike A, Radstake, Timothy RDJ, van Roon, Joel A
Publicado 2023

Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis

por Smith, Samantha Louise, Alexander, Sheree, Nair, Nisha, Viatte, Sebastien, Eyre, Stephen, Hyrich, Kimme L, Morgan, Ann W, Wilson, Anthony G, Isaacs, John D, Plant, Darren, Barton, Anne
Publicado 2023

Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomise...

por Fleischmann, Roy M, van der Heijde, Désirée, Strand, Vibeke, Atsumi, Tatsuya, McInnes, Iain B, Takeuchi, Tsutomu, Taylor, Peter C, Bracher, Marguerite, Brooks, David, Davies, John, Goode, Christopher, Gupta, Anubha, Mukherjee, Sumanta, O’Shea, Ciara, Saurigny, Didier, Schifano, Lorrie A, Shelton, Celia, Smith, Julia E, Wang, Millie, Wang, Reena, Watts, Sarah, Weinblatt, Michael E
Publicado 2023

Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthr...

por Schiff, M, Keiserman, M, Codding, C, Songcharoen, S, Berman, A, Nayiager, S, Saldate, C, Li, T, Aranda, R, Becker, J-C, Lin, C, Cornet, P L N, Dougados, M
Publicado 2008

Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study

por Panoutsopoulou, K, Southam, L, Elliott, K S, Wrayner, N, Zhai, G, Beazley, C, Thorleifsson, G, Arden, N K, Carr, A, Chapman, K, Deloukas, P, Doherty, M, McCaskie, A, Ollier, W E R, Ralston, S H, Spector, T D, Valdes, A M, Wallis, G A, Wilkinson, J M, Arden, E, Battley, K, Blackburn, H, Blanco, F J, Bumpstead, S, Cupples, L A, Day-Williams, A G, Dixon, K, Doherty, S A, Esko, T, Evangelou, E, Felson, D, Gomez-Reino, J J, Gonzalez, A, Gordon, A, Gwilliam, R, Halldorsson, B V, Hauksson, V B, Hofman, A, Hunt, S E, Ioannidis, J P A, Ingvarsson, T, Jonsdottir, I, Jonsson, H, Keen, R, Kerkhof, H J M, Kloppenburg, M G, Koller, N, Lakenberg, N, Lane, N E, Lee, A T, Metspalu, A, Meulenbelt, I, Nevitt, M C, O'Neill, F, Parimi, N, Potter, S C, Rego-Perez, I, Riancho, J A, Sherburn, K, Slagboom, P E, Stefansson, K, Styrkarsdottir, U, Sumillera, M, Swift, D, Thorsteinsdottir, U, Tsezou, A, Uitterlinden, A G, van Meurs, J B J, Watkins, B, Wheeler, M, Mitchell, S, Zhu, Y, Zmuda, J M, Zeggini, E, Loughlin, J
Publicado 2010

Local Diversification of Methicillin- Resistant Staphylococcus aureus ST239 in South America After Its Rapid Worldwide Dissemination

por Botelho, Ana Maria Nunes, Cerqueira e Costa, Maiana Oliveira, Moustafa, Ahmed M., Beltrame, Cristiana Ossaille, Ferreira, Fabienne Antunes, Côrtes, Marina Farrel, Costa, Bruno Souza Scramignon, Silva, Deborah Nascimento Santos, Bandeira, Paula Terra, Lima, Nicholas Costa Barroso, Souza, Rangel Celso, de Almeida, Luiz Gonzaga Paula, Vasconcelos, Ana Tereza Ribeiro, Narechania, Apurva, Ryan, Chanelle, O’Brien, Kelsey, Kolokotronis, Sergios-Orestis, Planet, Paul J., Nicolás, Marisa Fabiana, Figueiredo, Agnes Marie Sá
Publicado 2019

Lesion segmentation in breast ultrasound images using the optimized marked watershed method

por Shen, Xiaoyan, Ma, He, Liu, Ruibo, Li, Hong, He, Jiachuan, Wu, Xinran
Publicado 2021

The effect of tracer contact on return to care among adult, “lost to follow‐up” patients living with HIV in Zambia: an instrumental variable analysis

por Beres, Laura K., Mody, Aaloke, Sikombe, Kombatende, Nicholas, Lauren Hersch, Schwartz, Sheree, Eshun‐Wilson, Ingrid, Somwe, Paul, Simbeza, Sandra, Pry, Jake M., Kaumba, Paul, McGready, John, Holmes, Charles B., Bolton‐Moore, Carolyn, Sikazwe, Izukanji, Denison, Julie A., Geng, Elvin H.
Publicado 2021

Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa:...

por Ndjeka, Norbert, Campbell, Jonathon R, Meintjes, Graeme, Maartens, Gary, Schaaf, H Simon, Hughes, Jennifer, Padanilam, Xavier, Reuter, Anja, Romero, Rodolfo, Ismail, Farzana, Enwerem, Martin, Ferreira, Hannetjie, Conradie, Francesca, Naidoo, Kogieleum, Menzies, Dick
Publicado 2022

Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atheroscler...

por Charles-Schoeman, Christina, Buch, Maya H, Dougados, Maxime, Bhatt, Deepak L, Giles, Jon T, Ytterberg, Steven R, Koch, Gary G, Vranic, Ivana, Wu, Joseph, Wang, Cunshan, Kwok, Kenneth, Menon, Sujatha, Rivas, Jose L, Yndestad, Arne, Connell, Carol A, Szekanecz, Zoltan
Publicado 2023

Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies

por Zhou, Danlei, King, Emily H, Rothwell, Simon, Krystufkova, Olga, Notarnicola, Antonella, Coss, Samantha, Abdul-Aziz, Rabheh, Miller, Katherine E, Dang, Amanda, Yu, G Richard, Drew, Joanne, Lundström, Emeli, Pachman, Lauren M, Mamyrova, Gulnara, Curiel, Rodolfo V, De Paepe, Boel, De Bleecker, Jan L, Payton, Antony, Ollier, William, O'Hanlon, Terrance P, Targoff, Ira N, Flegel, Willy A, Sivaraman, Vidya, Oberle, Edward, Akoghlanian, Shoghik, Driest, Kyla, Spencer, Charles H, Wu, Yee Ling, Nagaraja, Haikady N, Ardoin, Stacy P, Chinoy, Hector, Rider, Lisa G, Miller, Frederick W, Lundberg, Ingrid E, Padyukov, Leonid, Vencovský, Jiří, Lamb, Janine A, Yu, Chack-Yung
Publicado 2023

Severe Maternal Morbidity and Mortality Among Immigrant and Canadian-Born Women Residing Within Low-Income Neighborhoods in Ontario, Canada

por Jairam, Jennifer A., Vigod, Simone N., Siddiqi, Arjumand, Guan, Jun, Boblitz, Alexa, Wang, Xuesong, O’Campo, Patricia, Ray, Joel G.
Publicado 2023